This research project aims to better understand and manage hereditary kidney cancer in Korean families. The main objectives are:
1) Create a central database that tracks families with a history of this type of cancer.
2) Figure out the genetic differences that exist between hereditary kidney cancer patients and those who get kidney cancer by chance.
3) Use UK’s health data to compare and further understand the genes responsible for hereditary kidney cancer in Korean families.
4) Offer guidelines on how to prevent this cancer by determining which family members are at a higher risk, and set up screening programs.
5) Design treatment plans that best suit these patients and their families.
6) Find markers in the body that can help predict how the disease might progress, to pave the way for better treatment strategies in the future.
Why is this research important?
Though hereditary kidney cancer is rare, affecting only 2-8% of kidney cancer cases, it’s crucial because there hasn’t been much research on this topic in Korea. Because this type of cancer isn’t common and doesn’t bring much profit, companies don’t invest in its research. This means it’s up to public health authorities to step in and focus on it. Kidney cancers can be very different from one another, and their progression can vary based on many factors. Studying families can give unique insights because some family members may be at high risk but never develop the disease. This hints that besides genes, other factors like environment and lifestyle might also play a role.
What will the public gain from this research?
1) A deeper understanding of the differences between hereditary kidney cancer and the more common type of kidney cancer.
2) Knowledge of what lifestyle or environmental factors might increase or decrease the risk of getting kidney cancer.
3) Tools and strategies to figure out which family members might be more at risk, leading to earlier and more targeted screenings.
4) Better treatment plans tailored for these patients and their families.
In conclusion, this research project is a comprehensive effort to tackle the challenges of understanding, preventing, and treating hereditary kidney cancer in Korea. Through collaboration and innovative methods, it hopes to shed light on this rare disease and offer better care and prevention strategies to those affected.